Celltrion
068270.KS
#801
Rank
$24.56 B
Marketcap
$118.62
Share price
-0.60%
Change (1 day)
-1.66%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Net assets

Net assets on the balance sheet as of June 2024 : $12.31 Billion USD

According to Celltrion 's latest financial reports the company has $12.31 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celltrion - Net assets on balance sheet (from 2007 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$$3.38 B-0.42%
2021-12-31$$3.40 B7.89%
2020-12-31$$3.15 B26.99%
2019-12-31$$2.48 B6.86%
2018-12-31$$2.32 B2.82%
2017-12-31$$2.26 B32.26%
2016-12-31$$1.70 B18.02%
2015-12-31$$1.44 B17.73%
2014-12-31$$1.23 B19.34%
2013-12-31$$1.03 B1.93%
2012-12-31$$1.01 B30.38%
2011-12-31$$0.77 B12.13%
2010-12-31$$0.69 B178.81%
2009-12-31$$0.24 B40.31%
2008-12-31$$0.17 B516.22%
2007-12-31$$28.7 M